Cancer Nursing, Royal Brompton and Harefield Hospitals, London, UK
Division of Nursing and Midwifery, The University of Sheffield, Sheffield, UK.
BMJ Open Respir Res. 2022 May;9(1). doi: 10.1136/bmjresp-2022-001252.
Malignant pleural mesothelioma (MPM) is characterised by poor prognosis and limited treatment options. However, a minority of patients can survive well beyond these bleak estimates. Little is known about the specific experiences and needs of long-term survivors and families.
The study aimed to gain in-depth understanding of the experiences of patients diagnosed with MPM 3 or more years, along with their main carer, and to determine the care and support needs of this group.
People diagnosed with MPM 3 or more years were recruited via asbestos and mesothelioma social media and support groups. Potential participants were asked to identify someone who acted as their main carer.
The study employed a cross-sectional qualitative interview design. A topic guide aided a conversational interview style, conducted remotely and recorded. Patient and carer pairs were interviewed jointly when possible, but were given an option for separate interviews if preferred. Fifteen patients, with 14 identifying a main carer, consented to participation.
Recorded interviews were transcribed verbatim, and then anonymised by the interviewer. Framework analysis was used to analyse the data iteratively and to develop final themes.
Three themes were developed. Participants 'Living beyond expectations' remained acutely aware that MPM was incurable, but developed a range of coping strategies. Periods of disease stability were punctuated with crises of progression or treatment ending, straining coping. 'Accessing treatment' was important for patients and carers, despite the associated challenges. They were aware options were limited, and actively sought new treatments and clinical trials. 'Support needs' were met by healthcare professionals, voluntary groups and social media networks.
Managing patients via regional MPM multidisciplinary teams, facilitating equal access to treatment and trials, could reduce patient and carer burden. Greater awareness and support around crisis points for this group could improve care.
恶性胸膜间皮瘤(MPM)的预后较差,治疗选择有限。然而,少数患者的存活时间远远超过这些黯淡的估计。对于长期幸存者及其家属的具体经历和需求知之甚少。
本研究旨在深入了解被诊断患有 MPM 3 年或以上的患者及其主要照顾者的经历,并确定该群体的护理和支持需求。
通过石棉和间皮瘤社交媒体和支持小组招募被诊断患有 MPM 3 年或以上的患者。要求潜在参与者确定一位作为其主要照顾者的人。
该研究采用了横断面定性访谈设计。主题指南辅助了对话式访谈风格,通过远程方式进行,并进行记录。如果可能的话,患者和照顾者对一起接受采访,但也提供了单独采访的选择。15 名患者同意参与,其中 14 名患者确定了主要照顾者。
记录的访谈被逐字转录,并由访谈者匿名。使用框架分析对数据进行迭代分析,以开发最终主题。
确定了三个主题。参与者“超越预期地生活”仍然敏锐地意识到 MPM 是无法治愈的,但发展了一系列应对策略。疾病稳定期会因进展或治疗结束而出现危机,这会给应对带来压力。“获得治疗”对患者和照顾者都很重要,尽管存在相关挑战。他们意识到选择有限,并积极寻求新的治疗方法和临床试验。“支持需求”由医疗保健专业人员、志愿组织和社交媒体网络满足。
通过区域间 MPM 多学科团队管理患者,为患者和照顾者提供平等的治疗和试验机会,可以减轻患者和照顾者的负担。提高对该群体危机点的认识和支持,可以改善护理。